MIF and D-DT are potential disease severity modifiers in male MS subjects

Gil Benedek(Oregon Health & Science University), Arthur A. Vandenbark(Oregon Health & Science University)
Proceedings of the National Academy of Sciences
September 18, 2017
Cited by 99


Related Papers